The management of glaucoma with drugs is mostly via the topical route, although these treatments have poor ocular bioavailability. Other problems limiting their therapeutic effect include pre-corneal clearance, corneal and ocular surface barriers, and the need for a long-term treatment regimen. Nanoparticle-mediated dr...
Matteo Capobianco, Marco Zeppieri, M. L. Salvetat et al.· Pharmaceuticals· 0 citations
The development and validation of robust OCT-based biomarkers have the potential to enable earlier diagnosis, improved disease monitoring, and personalised treatment strategies, and future research that integrates quantitative imaging, computational analysis, and longitudinal clinical data will be essential to fully re...
Lan-Xing Fu, Y. Luo, Nick Kopsachilis et al.· Diseases· 0 citations
The limits of using high-performing artificial intelligence systems in ocular image processing, which seldom lead to enhanced patient outcomes, are assessed and the scientific, clinical, and practical techniques required to close this gap are delineated.
Marco Zeppieri, Matteo Capobianco, Federico Visalli et al.· World Journal of Methodology· 0 citations
Artificial intelligence in ophthalmology encounters a continual challenge: Systems proficient in picture classification seldom yield quantifiable enhancements in patient outcomes. The primary concern is the disparity between pixel-level performance metrics and their clinical significance. Primary obstacles encompass da...
Marco Zeppieri, Matteo Capobianco, Federico Visalli et al.· World Journal of Methodology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
